Clinical studies demonstrate that estrogen replace ment therapy in postmenopausal women may enhance cogni tive function and reduce neurodegeneration associated with Alzheimer's disease and stroke, This study assesses whether physiologic levels of estradiol prevent brain injury in an in vivo model of permanent focal ischemia, Sprague-Dawley rats were ovariectomized; they then were implanted, immediately or at the onset of ischemia, with capsules that produced physiologi cally low or physiologically high 1713-estradiol levels in serum (10 or 60 pg/mL, respectively), One week after ovariectomy, ischemia was induced. Estradiol pretreatment significantly re duced overall infarct volume compared with oil-pretreated con-Until recently, estradiol, the primary hormone secreted by the ovary, has been thought to predominantly influ ence reproductive functions. It is now known that this pleiotropic hormone has profound effects on plasticity in the developing and adult brain (McEwen et aI., 1995). Recent clinical studies demonstrate that estradiol re placement in postmenopausal women ameliorates cogni tive dysfunction (Sherwin, 1994; Robinson et aI., 1994; Henderson et aI., 1996) and decreases the incidence and rate of neurodegeneration associated with diseases such as Alzheimer's disease (Henderson et aI., 1996; Paga nini-Hill and Henderson, 1994; Brenner et aI., 1994).
troIs (mean ± SO: oil = 241 ± 88; low = 139 ± 91; high = 132 ± 88 mm 3 ); this protective effect was regionally specific to the cortex, since no protection was observed in the striatum. Baseline and ischemic regional CBF did not differ between oil and estradiol pretreated rats, as measured by laser Doppler flowmetry. Acute estradiol treatment did not protect against ischemic injury. Our finding that estradiol pretreatment reduces injury demonstrates that physiologic levels of estradiol can pro tect against neurodegeneration. Key Words: Estrogen Neuroprotection-Cerebral ischemia-Stroke-Plasticity Menopause. 1991), and increases spine densities (Murphy and Segal, 1996) , few studies have examined this role in in vivo models of brain injury. Reports have been contradictory. Sex differences in postischemic necrosis revealed less neuronal pathology in female gerbils compared with male gerbils (Hall et aI., 1991) . Pharmacologic doses of estradiol have been reported to both exacerbate brain injury (Emerson et aI., 1993) and reduce mortality and brain damage (Simpkins et aI., 1997) in female rats. Hum and colleagues (1995) report that postischemic hyper emia was greater in female than in male rabbits and that pharmacologic levels of estradiol resulted in greater CBP during ischemia. Studies that administer precise, physi ologically relevant treatments to test for neuroprotection are lacking.
This study determined whether physiologically rel evant levels of estradiol protect against brain injury and if pretreatment is necessary to exert these effects. Our findings demonstrate that pretreatment with two biologi cally relevant doses of estradiol significantly protects against cerebral ischemia.
MATERIALS AND METHODS

Animals and experimental treatments
Female Sprague-Dawley rats (225 to 250 g) were maintained in a 14: 10 hour light-dark cycle with unrestricted access to food and water. Under methoxyflurane anesthesia, rats were bilaterally ovariectomized to eliminate endogenous estradiol production. Immediately after ovariectomy or at the onset of ischemia, silastic capsules (3.8 mm diameter, 30 mm length, 0.07 mL volume) were implanted subcutaneously. Animals re ceived a capsule filled with vehicle (sesame oil), a capsule filled with a low dose of 1713-estradiol (180 f,Lg/mL), or two capsules filled with a high dose of 1713-estradiol (I mg/mL).
Within 1 hour of implantation, the Silastic capsules produce a transient rise of estradiol in blood that stabilizes by 24 hours. After this transient rise, the capsules consistently release hor mone over time, producing stable levels of estradiol in serum (Wise et aI., 1981) .
Model of focal cerebral ischemia
One week after ovariectomy, rats were anesthetized with a mixture of ketaminelacepromazine (80.010.52 mg/kg intraper itoneally). In all animals, body temperature was monitored with a rectal probe and maintained at 36.5° to 37.SOC with a heating pad throughout surgery and recovery. The right femoral artery was cannulated for monitoring physiologic variables (pH, Po2, Peoz, glucose, and MABP) approximately 10 minutes before and 10 minutes after surgery. The right middle cerebral artery (MCA) was permanently occluded using a method modified from Zea Longa and colleagues (1989) . Briefly, a 4/0 black, monofilament suture (Ethicon) was fired at the tip and coated with polY-L-lysine (Belayev et aI., 1996) before surgery. The right common carotid artery was isolated through a neckline incision. The fascia and surrounding nerves were carefully dis sected from the internal carotid artery, the external carotid ar tery, and the common carotid artery. The external carotid artery was ligated with a 6/0 silk suture. The monofilament suture was advanced from the external carotid artery into the internal ca rotid artery for a distance of 17 mm, as measured from the bifurcation of the common carotid artery, effectively occluding the MCA.
Histologic preparation
Rats were killed 24 hours after the onset of ischemia. Brains were removed and sectioned into l-mm slices. Alternate slices were stained for 15 minutes in 2% triphenyltetrazolium chlo ride (Bederson et aI., 1986) , fixed in 10% buffered formalin, and quantified for infarct size. Total, cortical, and striatal isch emic injury was quantified using a computer-assisted imaging system (NIH Image, v. 1.60), and the size of the infarct is expressed as volume (mm3).
Quantification of serum estradiol levels
Trunk blood, collected when rats were killed, was centri fuged, and sera were frozen until the time of assay. Samples (0.5 mL) were analyzed for estradiol by radioimmunoassay after ether extraction.
Measurement of regional cerebral blood flow
In a separate experiment, ovariectomized and estradiol primed animals were anesthetized with a mixture of ketaminel acepromazine (80.0/0.05 mg/kg intraperitoneally). Tempera ture was monitored with a rectal probe and maintained at 36.5° to 37.5°C with a heating pad. Through a craniotomy, a nonin vasive laser Doppler probe was positioned (approximately 3 to 5 mm posterior to bregma, 4 mm lateral to midline) over the right parietal cortex over an area away from large pial vessels to obtain low, stable readings (Cholet et aI., 1997) . This region corresponds to an area affected by MCA occlusion, since isch emic injury spans the brain from approximately 4.2 mm ante rior to bregma to 5.8 mm posterior to bregma. Baseline mea surements were taken once a minute for 10 minutes; ischemia then was induced. Ten minutes after induction of ischemia, measurements were taken once a minute for 60 minutes. Data are expressed as 5-minute averages.
Data analysis
All data are expressed as mean ± SD. Infarct volumes in three group comparisons and serum estradiol levels were ana lyzed with one-way analysis of variance (ANOY A). Post hoc analyses were carried out with the Newman-Keuls test. Com parison between infarct volumes for acute treatment was ana lyzed with a Student's t test. Physiologic variables and laser Doppler measurements were analyzed using repeated measures ANOY A. All differences were considered significant at P < 0.05.
RESULTS
There were no significant differences in pH, blood gases, glucose, or MABP measurements among the treat ment groups of rats (Table 1) . Low and high physiologic levels of estradiol pretreatment significantly reduced overall infarct volume compared with oil-treated controls [F ( 2 . 31 ) = 5.14; P = 0.012] (Fig. IA) . Low and high physiologic estradiol pretreatment exerted an equivalent degree of neuroprotection.
The total infarcts were further analyzed by region to compare treatment effect on cortical and striatal infarcts. Estradiol pretreatment reduced the cortical infarct by over 60% in low-and high-estradiol-primed animals when compared with oil-treated controls [F ( 2 . 31) = 5.68; P < 0.008] (Fig. lB) . In contrast, estradiol did not exert a significant effect in the striatum of low-and high estradiol-primed rats compared with oil-treated controls [F ( 2 . 3J) = 1.78; P = 0.18] (Fig. IC) . When hormone was Physiologic measures on oil, low estradiol, and high estradiol pretreated rats were obtained from arterial samples.
Blood pH, P02, Pe02, and glucose values (n = 9-1l/group) were obtained approximately 10 minutes before and 10 minutes after onset of ischemia. Mean arterial blood pressure (MABP) (n = 3-5/group) measurements were also taken at these times. There were no significant differences among the treatment groups. Values represent mean ± SO.
J en 0 administered at the time of the MCA occlusion, we did not detect any significant protective effect [F O. J6) = 1.04; P = 0. 18] (Fig. 2) . Figure 3 shows serum 1713-estradiol concentrations in ovariectomized rats pretreated with Silastic capsules. The low and high estradiol serum concentrations result ing from pretreatment were significantly different from each other and from the oil-treated controls [F ( 2.J5) = 84.48, P < 0.0000 1]. In our paradigm of hormone re placement, low-dose estradiol pretreatment produces se rum levels equivalent to endogenous, circulating levels in adult female Sprague-Dawley rats. High-dose estra diol replacement produces serum levels equivalent to the transient, preovulatory estradiol surge in the rats (De Paolo et aI., 1979) . When low-dose estradiol is admin istered at the time of MCA occlusion (acute treatment), estradiol levels in blood immediately rise to proestrous values. These values stabilize, by 24 hours, to endog enous levels of estradiol, which mimic other days of the estrous cycle (Wise et aI., 198 1) .
In a separate experiment, regional CBF was measured by laser Doppler flowmetry through a craniotomy over an area affected by MCA occlusion on the right parietal cortex. Estradiol pretreatment did not alter the normal, or nonischemic, perfusion of blood to the cortex (oil: n = 5, 48.8 ± 6.7; low-dose estradiol: n = 5, 45.8 ± 5.3; high-dose estradiol: n = 4, 46.6 ± 6.2) [F ( 2.11) = 0.34; P = 0.72]. Furthermore, regional CBF after onset of ischemia did not differ between oil-pretreated and low dose estradiol-pretreated rats [F ( l A ) = 0.0 1; P = 0.92] (Fig. 4) . The reduction of cortical blood flow in response to ischemia in oil-and estradiol-pretreated rats is within the range of reductions observed in ischemic penumbra, or secondarily compromised tissue (Nedergaard, 1996) .
DISCUSSION
Our data clearly demonstrate, for the first time, that physiologic concentrations of estradiol greatly attenuate the extent of brain damage by permanent cerebral isch emia. Pretreatment with estradiol reduces infarct size by almost 50%. In contrast, we observed no protective ef fect when estradiol was administered immediately after the MCA was occluded. Since estradiol priming of the brain is necessary for neuroprotection, our findings sug gest that the presence of estradiol exerts its protective effect by influencing the expression of genes that en hance neuronal survival.
A study reports the effects of pharmacologic levels of estradiol in a reperfusion model of ischemia. Although both studies demonstrate that 1713-estradiol exerts protective effects against cerebral ischemia, several important differences in the results should be emphasized. First, in the previous study, there were significantly different from the hormone levels of oil pretreated controls (n = 5). Low and high estradiol serum con centrations also were significantly different from each other (P < 0.0002). Values represent mean ± SO. was substantial incidence of mortality in ovariectomized rats, which was reduced by estradiol treatment. In con trast, in the current study, only five animals died, and they were equally distributed among the treatment groups. This difference in mortality may result from the more invasive surgical method or the strain of rats used in the former study, or both. Second, treatment with pharmacologic levels of estradiol initiated after surgery protected against injury. In contrast, using our experi mental paradigm, physiologic estradiol treatment before ischemia was essential to demonstrate a protective effect. The differences between our results suggest that es tradiol may exert neuroprotective effects through differ ent mechanisms. Previous studies suggest that estradiol may act through receptor-mediated genomic (McEwen et al., 1995) or membrane-activated nongenomic pathways (Watters et al., 1997; Zhou et al., 1996; Weaver et al., 1997; Goodman et al., 1996) . For example, pharmaco logic doses of estradiol can act nongenomically to reduce oxidative injury, possibly by scavenging reactive oxygen species (Goodman et al., 1996) . It is likely that the type of injury (reperfusion or permanent ischemia) or the treatment paradigm (pharmacologic or physiologic) may determine which mechanisms of estradiol action pre dominate.
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Our findings that physiologic concentrations of estra diol exert a profound neuroprotective effect highlight the vulnerability of a hypoestrogenic brain to injury or ab normal function. The data suggest that postmenopausal women may be at greater risk for brain injury or may suffer greater neural dysfunction during normal aging than women who receive estradiol replacement therapy. .In our paradigm of hormone replacement, the high dose of estradiol pretreatment achieved serum concentrations of hormone comparable with those that we observe on proestrus, the preovulatory phase of the reproductive cycle. The low dose of estradiol pretreatment resulted in basal concentrations of estradiol that circulate on other days of the estrous cycle (DePaolo et aI., 1979) . In our paradigm of acute, low-dose estradiol administration, no protection was observed, despite the transient proestrous like values of estradiol produced immediately upon im plantation (Wise et aI., 1981) .
Our data show that pretreatment with both physiologic low and physiologic high doses were equally effective at reducing the size of the ischemic injury. Maximal pro tection is achieved with the low level of estradiol pre treatment. This equivalent protection by low-and high dose estradiol pretreatment may reflect the substantial occupancy of nuclear estrogen receptors that is already present, even with the low level of estradiol treatment (Camp and Barraclough, 1985) .
Estradiol exerted a striking protective effect in the cortex compared with the striatum. This may reflect dif ferential blood perfusion to cortex and striatum after per manent occlusion of the MCA; however, it is unlikely that this explains the extent of the difference (Tsuchidate et aI., 1997) . Furthermore, estradiol exerted a protective effect in the cortex, despite an equivalent reduction in regional cortical blood flow between oil-and estradiol pretreated rats. Alkayed and colleagues (1998) report no differences in ischemic cortical blood flow in gonadally intact compared with ovariectomized rats using quanti tative autoradiography. Taken together, these results sug gest that estradiol acts as a neuroprotective factor in the cortex through blood flow-independent mechanisms.
Several lines of evidence suggest that the cortex is an important target for estrogen action. Both the alpha iso form of estradiol receptor and the newly discovered beta isoform have been identified with abundance in cortex but not in the striatum (Shughrue et aI., 1997) , suggesting that the cortex is directly modified by receptor-mediated, estradiol-induced plasticity. Various cellular and mo lecular mechanisms may explain estradiol's neuroprotec tive abilities. Estradiol enhances neurite outgrowth in cortical explant cultures (Toran-Allerand, 1991) and pre vents cell death in dispersed cortical cultures (Singer et aI., 1996; Brooke et aI., 1997) . In addition, it increases the expression of neurotrophins and their receptors in several areas of the brain, including cortex (Singh et aI., 1995; Toran-Allerand, 1996) , possibly through direct ac tions at the level of transcriptional activation of the genes.
Alternatively, estradiol may modulate the effects of glutamate release by altering NMDA receptor function (Woolley et aI., 1997; Weaver et aI., 1997) and reducing calcium mobilization (Brooke et aI., 1997) . It may alter the balance of proapoptotic and antiapoptotic genes (Huang et aI., 1997; Spyridopoulos et aI., 1997) . Finally, estradiol may influence the expression of proteins in volved in synaptic plasticity (Shughrue and Dorsa, 1993) or microtubule stability (Ferreira and Caceres, 1991) .
In summary, our results clearly establish that physi ologic concentrations of estradiol play a neuroprotective role in the injured brain. Furthermore, our findings sug gest that estradiol may act by altering factors that favor neuronal viability and attenuate cell death through blood flow-independent mechanisms.
